Cytokine Expression and Cell Activation in Inflammatory Arthritis
Year: 1996
Type: book-chapter
Abstract: This chapter focuses upon the expression and role of cytokines in rheumatoid arthritis (RA) that is one of the most intensively studied and best characterized human inflammatory diseases. The study of cytokines in animal models of arthritis and in seronegative arthritis has revealed both similarities and differences with RA. The role of cytokines in animal models and in seronegative arthritis is discussed in the chapter in relation to their role in RA. Experiments with animal models of arthritis and clinical trials with RA patients suggesting that interventions aimed at inhibiting cytokines have significant therapeutic potential represent a particularly exciting development. Several potential problems with therapeutic blockade of cytokine activity include—potential lack of long term efficacy; problems with toxicity; potential need to inhibit multiple cytokines; immune responses against biopharmaceuticals, such as antibodies; unexpected consequences from perturbing cytokine networks; and difficulty in targeting therapy to sites of inflammation, thus avoiding generalized immunosuppression. Some of these problems may be overcome by targeting signaling pathways or transcription factors that are activated by cytokines and may be more amenable to inhibition by more conventional therapeutic agents. An example of a successful application of this approach is the prevention of LPS-induced lethal toxicity in mice by protein tyrosine kinases inhibitors. A greater understanding of which cytokines are the most important in pathogenesis and the mechanisms of cellular responses to these cytokines is useful in guiding the design of effective and safe therapies.
Source: Advances in immunology
Author: Lionel B. Ivashkiv
Institutions: Hospital for Special Surgery, Cornell University
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W1843444485
